A phase-I, open label clinical trial to assess the safety & tolerability of qHPV vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults.

Hitt Sharma,K Anil,Sameer Parekh,Pramod Pujari,Sunil Shewale,Shivani Desai,R L Madhusudhan,Jaya Patel,Anand Eswaraiah,Harish Rao,Sunil Gairola,Umesh Shaligram

Vaccine: X（2023）

引用 0|浏览1

暂无评分

摘要

qHPV vaccine manufactured by SIIPL was found to be safe and well tolerable in adults. Further clinical development should continue to assess safety and immunogenicity, in the target population following recommended 2 and 3-dose schedule. - CTRI/2017/02/007785.

查看译文

关键词

qHPV,Safety,Adult,Phase I,Vaccine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要